Speech-Language Pathologists in Fairfield, ME Accepting Medicare

4 Speech-Language Pathologists found. Showing 1 - 4

Ms. Mary J Sullivan, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 95 Skowhegan Rd, Maine Center For Integrated Rehab, Fairfield, ME 04937 Phone: 207-453-1330

Lucinda Rasmussen, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 95 Skowhegan Rd, Fairfield, ME 04937 Phone: 207-453-1330

Mrs. Dana M Haddad, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 95 Skowhegan Rd, Fairfield, ME 04937 Phone: 207-453-1330

Heidi Lynn Thacker Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8 School St, Fairfield, ME 04937 Phone: 207-453-4200

News Archive

First three-dimensional projectome map of intact brain

It would be hard to understand how a city is organized without knowledge of the course of all of its streets. Scientists confront the same problem when trying to understand the functioning of the brain. In the case of vertebrates, we only have fragmentary knowledge of which nerve cells send their connections, so-called axons, into certain regions of the brain.

Cannabis users appear to lack motivation

Researchers found that dopamine levels in a part of the brain called the striatum were lower in people who smoke more cannabis and those who began taking the drug at a younger age.

Private sector becoming more involved in efforts to reach global health development goals

In a post in the Guardian's "Sustainable Business" blog, Lisa Herman, managing director of the global health practice area at consulting firm FSG, and Mike Stamp, a senior consultant with FSG, discuss "a new guide for companies on how to participate in global action on women and children's health" recently launched at the London Family Planning Summit.

Elevated allostatic load may impact treatment completion and breast cancer survival outcomes

Elevated allostatic load was associated with a lower likelihood of completing chemotherapy and a lower overall survival rate in patients with lymph node-positive or high-risk lymph node-negative HER2-negative breast cancer, according to results presented at the 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held online October 6-8, 2021.

Read more Medical News

› Verified 5 days ago